Related Experiment Video
Updated: Aug 9, 2025

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
Published on: April 4, 2019
RSV through the COVID-19 pandemic: Burden, shifting epidemiology, and implications for the future
Renato T Stein1, Heather J Zar2,3
1Infant Center, Department of Pediatrics, School of Medicine, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil.
Insights
Respiratory syncytial virus (RSV) significantly impacts global health, especially in young children. The COVID-19 pandemic altered RSV patterns, offering new insights for prevention strategies.
Area of Science:
- Virology
- Epidemiology
- Public Health
Background:
- Respiratory syncytial virus (RSV) poses a significant global health challenge, particularly for children under five.
- Current treatment options are limited to supportive care, with palivizumab available for high-risk infants.
- RSV is tentatively linked to the development of asthma and wheezing in some children.
Purpose of the Study:
- To review the global burden and epidemiology of RSV.
- To analyze the impact of the COVID-19 pandemic and nonpharmaceutical interventions (NPIs) on RSV seasonality and transmission dynamics.
- To discuss how recent epidemiological shifts inform future RSV prevention strategies.
Main Methods:
- Review of existing literature and epidemiological data on RSV.
- Analysis of changes in RSV seasonality and incidence during the COVID-19 pandemic.
- Examination of the association between RSV and subsequent development of asthma or wheezing.
Main Results:
- The COVID-19 pandemic and NPIs led to significant disruptions in typical RSV seasons, including absence and out-of-season surges.
- These epidemiological shifts provide a unique opportunity to study RSV transmission patterns.
- Understanding these changes is crucial for refining public health responses and preventive measures.
Conclusions:
- RSV remains a critical public health concern with evolving epidemiological patterns.
- The pandemic-induced changes in RSV dynamics offer valuable lessons for respiratory virus control.
- New data necessitate a re-evaluation of existing and future strategies for RSV prevention.
Abstract:
Respiratory syncytial virus (RSV) represents a major global healthcare burden, particularly in those under 5 years of age. There is no available vaccine, with treatment limited to supportive care or palivizumab for high-risk children. Additionally, although a causal relationship has not been established, RSV has been associated with the development of asthma or wheezing in some children. The COVID-19 pandemic and the introduction of nonpharmaceutical interventions (NPIs) have caused substantial changes to RSV seasonality and epidemiology. Many countries have experienced an absence of RSV during the time of a typical season, followed by an out-of-season surge upon relaxation of NPI use. These dynamics have disrupted traditional RSV disease patterns and assumptions, but also provide a unique opportunity to learn more about the transmission of RSV and other respiratory viruses, as well as inform future approaches to RSV preventive strategies. Here, we review the RSV burden and epidemiology through the COVID-19 pandemic and discuss how new data may affect future decisions regarding RSV prevention.
Related Concept Videos
Principles of Disease Surveillance
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Viruses with RNA Genomes
Steps in Outbreak Investigation
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology

